<?xml version="1.0" encoding="UTF-8"?>
<Label drug="sodium5" track="TAC2017_ADR">
  <Text>
    <Section name="adverse reactions" id="S1">    ADVERSE REACTIONS

  Post-Marketing Adverse Reactions

  The following adverse reactions have not been reported with 3% and 5% Sodium Chloride Injection, USP but may occur:



 *    hyperchloremic metabolic acidosis, 
 *    hypersensitivity/infusion reactions, including hypotension, pyrexia, tremor, chills, urticaria, rash, and pruritus, 
 *    Infusion site reactions, such as thrombosis, phlebitis, irritation, infusion site erythema, injection site streaking, burning sensation, infusion site urticaria. 
    If an adverse reaction does occur, discontinue the infusion, evaluate the patient, institute appropriate therapeutic countermeasures, and save the remainder of the fluid for examination if deemed necessary.
</Section>
  </Text>
  <Mentions />
  <Relations />
  <Reactions />
</Label>
